Merck, Sharp, and Dohme (MSD) has announced it is to build a state of the art life sciences R&D facility in London, creating around 950 jobs. Known as Merck & Co in the US, the company said the ...

I’m talking about Vermont farm stays — private ... It is ideally situated at the base of the Green Mountains and surprisingly vibrant for a village of fewer than 4,000 residents.

In a decision filed March 28, Hon. Steven C. Seeger granted The Lansing Journal’s motion to dismiss the lawsuit filed by Lan-Oak Park District ...

Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

Merck, Black Hills, and Virtus Investment Partners are good choices for investors seeking reliable passive income. Their ...

The companies have entered into an exclusive license agreement for HRS-5346. (Image Credits: Pixabay) Merck on Tuesday announced that it has signed a deal with Jiangsu Hengrui Pharmaceuticals ...

Merck & Co – known as MSD outside of the US and Canada – and Cyprumed have entered into a partnership aimed at developing oral formulations of Merck’s peptides, with the deal worth over $493m. The ...

Merck recently experienced a significant corporate governance event when multiple shareholder proposals were announced, with the company recommending against them for the upcoming annual meeting.

Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to jointly develop and commercialize an experimental heart disease ...